Pharmacy Market BUZZ

Market News, Products, Services, and Trends

Elimination of the DATA-Waiver Program: How will it Impact the Opioid Crisis?

Have you heard about the signing of the Consolidated Appropriations Act of 2023?

With this Act, Congress eliminated the DATA-Waiver Program. This means:

A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder.

• There are no longer any limits or patient caps on the number of patients a prescriber may treat for opioid use disorder with buprenorphine.

All prescriptions for buprenorphine only require a standard DEA registration number.


Today's Posts